Analysis of MHC Class I Expression in HPV 16 Positive Cervical Carcinomas, in Relation to C-MYC Overexpression

[1]  C. Meijer,et al.  Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas , 1994, The Journal of experimental medicine.

[2]  C. Meijer,et al.  MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression. , 1993, Oncogene.

[3]  C. Meijer,et al.  Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. , 1993, British Journal of Cancer.

[4]  T. Iwasaka,et al.  Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas. , 1992, Gynecologic oncology.

[5]  J. Pound,et al.  Modulation of MHC antigen expression by viruses and oncogenes , 1991, Immunology Today.

[6]  J. Baak,et al.  Nonradioactive RNA in situ hybridization detection of human papillomavirus 16-E7 transcripts in squamous cell carcinomas of the uterine cervix using confocal laser scan microscopy. , 1991, The American journal of pathology.

[7]  H. Hausen.  Human papillomaviruses in the pathogenesis of anogenital cancer. , 1991 .

[8]  A. Rustgi,et al.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product , 1991, Nature.

[9]  S. Schneider-Maunoury,et al.  Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression , 1991, Journal of virology.

[10]  Robert DeMars,et al.  Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter , 1991, Nature.

[11]  S. Beck,et al.  Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters , 1990, Nature.

[12]  P. Stern,et al.  Loss of MHC class‐I expression in cervical carcinomas , 1990, International journal of cancer.

[13]  P. Yaciuk,et al.  TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains , 1990, Cell.

[14]  H. Ploegh,et al.  Suppression of class I human histocompatibility leukocyte antigen by c- myc is locus specific , 1989, The Journal of experimental medicine.

[15]  K. Münger,et al.  The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A , 1988, Cell.

[16]  R. Versteeg,et al.  c‐myc down‐regulates class I HLA expression in human melanomas. , 1988, The EMBO journal.

[17]  M. A. Saper,et al.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens , 1987, Nature.

[18]  C. Croce,et al.  Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Evan,et al.  The protein encoded by the human proto-oncogene c-myc. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[20]  L. T. Peltenburg,et al.  Relationship between myc oncogene activation and MHC class I expression. , 1993, Advances in cancer research.

[21]  A. Eb,et al.  Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells , 1983, Nature.